Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Pancreatic Cancer Detection Consortium

City of Hope Medical Center · NCT06388967

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
2000
US sites recruiting
9
Study start
March 15, 2023
Record last updated
September 28, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

Being studied: PANcreatic cancer Exosome Early detectiON (PANXEON)

Conditions: Pancreatic Cancer; Pancreatic Carcinoma; Pancreatic Adenocarcinoma; Pancreatic Ductal Adenocarcinoma; Pancreatic Neoplasms; Pancreatic Cancer Stage I; Pancreatic Cancer Stage; Pancreatic Cancer Resectable; Pancreatic Cancer Stage 0; Pancreatic Cancer Stage II; Pancreatic Cancer Stage III; Pancreatic Cancer, Adult; Pancreatic Cancer Non-resectable

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition)
  • Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment.
  • Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls)

Exclusion Criteria

  • Lack of written informed consent.

Recruiting US locations

  • Translational Genomics Research Institute

    Phoenix, AZ 85004

    Site contact: Daniel Von Hoff · dvh@tgen.org

  • City of Hope Medical Center

    Monrovia, CA 91016

    Site contact: Ajay Goel, PhD · 626-218-3452 · AJGOEL@COH.ORG

  • OSF HealthCare

    Peoria, IL 61637

    Site contact: Chandler Wilfong · chandler.d.wilfong@osfhealthcare.org

  • Ochsner Medical Center

    Jefferson, LA 70121

    Site contact: John Bolton · jbolton@ochsner.org

  • Atlantic Health System

    Morristown, NJ 07960

    Site contact: Angela Alistar · angela.alistar@atlantichealth.org

  • AHN Cancer Institute at Allegheny General Hospital

    Pittsburgh, PA 15212

    Site contact: Ali Zaidi, MD · ali.zaidi@ahn.org

  • Piedmont Medical Center

    Rock Hill, SC 29732

    Site contact: Andrew Page · Andrew.Page@piedmont.org

  • MultiCare Cancer Institute - Tacoma General Hospital

    Tacoma, WA 98405

    Site contact: Alex Cantafio, MD · alex.cantafio@multicare.org

  • Medical College of Wisconsin

    Milwaukee, WI 53226

    Site contact: Douglas Evans · devans@mcw.edu

Study contacts (from the official record)

  • Ajay Goel, PhD · 6262183452 · AJGOEL@COH.ORG
Pancreatic Cancer Detection Consortium (NCT06388967) | Bored Studies